Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Jen Psaki roasted Trump for "nodding off" during an Oval Office event as "of all things, really, dementia, obesity and sleep ...

With 50 per cent of heart attacks now striking people below the age of 50, and 60 per cent of Delhi schoolchildren obese, the ...

Massive SNAP cuts could deprive millions of Americans of food aid, burden states, and increase hunger, health issues, and ...

Women using combined hormonal contraceptives lost less weight and had fewer restricted calories while involved in a ...

Doctors have long known that too little or interrupted sleep raises the risk of heart disease. But heart experts say this ...

Medicare’s coverage of GLP-1 therapies is beginning to shift, and the implications for retirees could be significant. In this ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

The investigational endoscopic procedure may help patients maintain weight loss or lose more weight 3 months after GLP-1 receptor agonist therapy discontinuation.

Fake ‘train attack’ imagery and child obesity stats - Round-up of fact checks from the last week compiled by Full Fact.

A new deal with major drugmakers, unveiled by U.S. President Donald Trump on Thursday, aims to expand coverage and cut prices for popular weight-loss drugs south of the border.